SCHEMBL903801

SCHEMBL903801

ClC(Cl)c1cc2ccccc2s1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.46
CYP1A2 P05177 2/20 0.46
PTGES O14684 1/20 0.46
LMNA P02545 1/20 0.46
LTA4H P09960 1/20 0.46
GAA P10253 1/20 0.46
ALOX15 P16050 1/20 0.46
ALOX12 P18054 1/20 0.46
ALOX5AP P20292 1/20 0.46
LOX P28300 1/20 0.46
EPHX2 P34913 1/20 0.46
PTGS2 P35354 1/20 0.46
LTB4R Q15722 1/20 0.46
CYP2A6 P11509 3/20 0.44
ASIC3 Q9UHC3 1/20 0.44
LOXL2 Q9Y4K0 1/20 0.44
MGLL Q99685 1/20 0.44
BCL2L1 Q07817 1/20 0.42
CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2161082 0.83 ALOX5 (0.51) ALOX5CYP1A2PTGESLMNALTA4H
SCHEMBL28235218 0.80 ALOX5 (0.45) ALOX5CYP1A2PTGESLMNALTA4H
SCHEMBL6026187 0.78 ALOX5 (0.46) ALOX5CYP1A2PTGESLMNALTA4H
SCHEMBL79534 0.78 ALOX5 (0.54) ALOX5CYP1A2PTGESLMNALTA4H
SCHEMBL2963101 0.78 ALOX5 (0.50) ALOX5CYP1A2PTGESLMNALTA4H
SCHEMBL14034242 0.76 OPRM1 (0.41) ALOX5CYP1A2PTGESLMNALTA4H
SCHEMBL4361286 0.75 ALOX5 (0.51) ALOX5CYP1A2PTGESLMNALTA4H
SCHEMBL19880957 0.75 MGLL (0.50) ALOX5CYP1A2PTGESLMNALTA4H
SCHEMBL16399862 0.75 ALOX5 (0.55) ALOX5CYP1A2PTGESLMNALTA4H
SCHEMBL139543 0.75 ALOX5 (0.55) ALOX5CYP1A2PTGESLMNALTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012041014-A1 TETRACYCLIC INDOLE DERIVATIVES FOR TREATING HEPATITIS C VIRUS INFECTION MERCK SHARP & DOHME CORP. (US) 2012-04-05 WO disclosed